Behind the Paper

The Story Behind "Aptamer Nanotechnology Bolsters COVID-19 Therapeutic Strategies"

This research provides a comprehensive review of aptamer-based strategies that target SARS-CoV-2, offering a promising avenue for blocking the virus. Behind this groundbreaking paper lies a tale of collaboration across borders, and a quest for the most comprehensive aptamer summary ever compiled.

Published in Chemistry, Materials, and Biomedical Research

Go to the profile of Dan Wang
Dan Wang
Dr, University of Bonn
The Story Behind "Aptamer Nanotechnology Bolsters COVID-19 Therapeutic Strategies"
Like
Go to the profile of India Ambler
Go to the profile of Yijia Li
Go to the profile of Yuanxin Zhang

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

Share with...

...or copy the link

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Explore the Research

SpringerLink
SpringerLink SpringerLink

Aptamer-engaged nanotherapeutics against SARS-CoV-2 - Discover Nano

The COVID-19 pandemic, caused by the virus SARS-CoV-2 infection, has underscored the critical importance of rapid and accurate therapeutics. The neutralization of SARS-CoV-2 is paramount in controlling the spread and impact of COVID-19. In this context, the integration of aptamers and aptamer-related nanotherapeutics presents a valuable and scientifically significant approach. Despite the potential, current reviews in this area are often not comprehensive and specific enough to encapsulate the full scope of therapeutic principles, strategies, advancements, and challenges. This review aims to fill that gap by providing an in-depth examination of the role of aptamers and their related molecular medicine in COVID-19 therapeutics. We first introduce the unique properties, selection, and recognition mechanism of aptamers to bind with high affinity to various targets. Next, we delve into the therapeutic potential of aptamers, focusing on their ability to inhibit viral entry and replication, as well as modulate the host immune response. The integration of aptamers with nucleic acid nanomedicine is explored. Finally, we address the challenges and future perspectives of aptamer and nucleic acid nanomedicine in COVID-19 therapeutics, including issues of stability, delivery, and manufacturing scalability. We conclude by underscoring the importance of continued research and development in this field to meet the ongoing challenges posed by COVID-19 and potential future pandemics. Our review will be a valuable resource for researchers and clinicians interested in the latest developments at the intersection of molecular biology, nanotechnology, and infectious disease management.

Introduction

The COVID-19 pandemic has turned the world on its head, prompting a global quest for effective therapeutic strategies. The paper is a narrative of a postdoctoral researcher’s journey from China to Germany, invited by the Journey Editor, and inspired by the different approaches to pandemic control and treatment between the two countries.
In this research, we conducted a thorough literature review to identify key studies on aptamer-based therapeutics for COVID-19. Additionally, we analyzed the integration of DNA nanotechnology to enhance the efficacy of aptamer-based treatments. The review covers various aptamer strategies, including their design, synthesis, and application in vitro and in vivo.

A Journey Across Continents

Our corresponding author embarked on an academic journey from China to Germany to pursue postdoctoral research. The invitation to contribute to the Springer Nature came as a recognition of his expertise and a call to delve into the pressing issues of the COVID-19 and Post-COVID-19 pandemic.

The Dream Team

This isn't just a paper; it's a testament to what happens when the brightest minds come together. Scientists from multiple related institutions have joined forces to produce what is poised to be the most exhaustive summary of aptamer strategies in the fight against COVID-19.

The Buzz

In the world of academia, this paper is already creating a buzz. It's not just about the science—it's about the story of how science is done. Why settle for less when you can have the best? Aptamer is a programmable "chemical antibody". This review is set to become the go-to guide for aptamer-based COVID-19 therapeutics, leaving no stone unturned in its quest for comprehensiveness.


Why This Matters

For those in the know, this paper is already making waves. It's not just another study on COVID-19; it's a game-changer in the therapeutic landscape. And for the rest of us? It's a glimpse into the future of medicine, where nanotechnology and aptamers join forces to take on the world’s most pressing health challenges.


Citation Potential

This isn't just a paper; it's a potential citation magnet. With its unique narrative and comprehensive review, it's set to leave a lasting impression on readers and inspire future research.
Cite this: Aptamer-engaged nanotherapeutics against SARS-CoV-2

Go to the profile of Dan Wang
Dan Wang
Dr, University of Bonn

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Sign In Register

Follow the Topic

Analytical Chemistry
Physical Sciences > Chemistry > Analytical Chemistry
Biomedical Research
Life Sciences > Health Sciences > Biomedical Research
Molecularly targeted therapy
Life Sciences > Health Sciences > Clinical Medicine > Therapeutics > Drug Therapy > Molecularly targeted therapy
Nanobiotechnology
Physical Sciences > Materials Science > Nanotechnology > Nanobiotechnology

Recommended Content

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.